Evidence map›Paper›PMID 42154144›Full record

ArticleApplied biochemistry and biotechnology2026

Parameter Optimization and Regulatory Mechanism of Cold Plasma Pretreatment for Enhancing Intracellular Polysaccharides Yield in Irpex lacteus.

Zhidan Liu, Yumeng Tang, Xiaohui Shi, Jianqi Han, Dongze Niu, Fan Zhang, Xia Yi, Jie Zhu

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhidan LiuNational-Local Joint Engineering Research Center for Biomass Refining and High-Quality Utilization, School of Petrochemical Engineering, Changzhou University, Changzhou, 213164, China.
Yumeng TangSchool of Pharmacy & School of Biological and Food Engineering, Changzhou University, Changzhou, Jiangsu, 213164, China.
Xiaohui ShiNational-Local Joint Engineering Research Center for Biomass Refining and High-Quality Utilization, School of Petrochemical Engineering, Changzhou University, Changzhou, 213164, China.
Jianqi HanNational-Local Joint Engineering Research Center for Biomass Refining and High-Quality Utilization, School of Petrochemical Engineering, Changzhou University, Changzhou, 213164, China.
Dongze NiuNational-Local Joint Engineering Research Center for Biomass Refining and High-Quality Utilization, School of Petrochemical Engineering, Changzhou University, Changzhou, 213164, China.
Fan ZhangHoekbio BioTech Co., Ltd., Wuxi, Jiangsu, 213164, China.
Xia YiNational-Local Joint Engineering Research Center for Biomass Refining and High-Quality Utilization, School of Petrochemical Engineering, Changzhou University, Changzhou, 213164, China. mote_13@cczu.edu.cn.ORCID http://orcid.org/0000-0002-0260-4057
Jie ZhuNational-Local Joint Engineering Research Center for Biomass Refining and High-Quality Utilization, School of Petrochemical Engineering, Changzhou University, Changzhou, 213164, China. zhujie@cczu.edu.cn.ORCID http://orcid.org/0000-0002-8602-717X

Funding

National Natural Science Foundation of China 22278040Scientific Research Foundation of Changzhou University ZMF22020021State Key Laboratory of Chemical Resource Engineering CRE-24-C004
6 · The paper itself

Abstract

The promise of intracellular polysaccharides (IPS) from Irpex lacteus as pharmaceuticals and functional foods due to the antioxidant and immunomodulatory activities, is hindered by low yield for industrial applications. Cold plasma, a non-thermal, residue-free microbial metabolism regulator, has not been used for IPS synthesis for I. lacteus. An IPS-producing strain was newly isolated and identified, sharing 99.68% identity with I. lacteus PJC74. The polysaccharide was composed of fucose, galactose, glucose, xylose, mannose, ribose, and galacturonic acid in a molar ratio of 0.62: 1.96: 75.92: 3.79: 10.89: 3.90: 2.91, as quantified by HPAEC. IPS yield was raised to 13.89% (mg/g dry mycelium) by cold plasma treatment (140 W, 15 s, and 135 Pa) optimized via single-factor and L

Indexed as

BasidiomycotaFungal PolysaccharidesPlasma GasesPolysaccharidesFungal PolysaccharidesPlasma GasesPolysaccharidesCold plasmaIntracellular polysaccharidesIrpex lacteusProteomics

Identifiers

PMID42154144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.